MISSISSAUGA (October 17, 2022) Bora Pharmaceuticals, a full-service contract development and manufacturing organization (CDMO), has appointed Don Liscombe as their Vice President and General Manager.
Bora Pharmaceutical Laboratories Inc. (Zhunan), a division of Bora Pharmaceuticals has partnered with TaiRx, Inc., a premier Taiwan new drug development company, to manufacture a novel anticancer.
Bora establishes a lead position in Taiwan's CDMO sector.
Bora establishes a leadership position in Taiwan's CDMO sector and plans to expand into the global CDMO market
TAIWAN – Fast-growing contract development and manufacturing organization (CDMO) BORA Pharmaceuticals, has announced a planned investment of $10 million to expand its Oral Solid Dose capabilities.
Bora Pharmaceuticals, a leading full-service contract development and manufacturing organization (CDMO), has appointed Sally Langa as its new Global SVP Sales and Marketing to help drive the.
Bora Pharmaceutical Services Inc., a division of Bora Pharmaceuticals, has announced that its Mississauga, Ontario contract manufacturing and packaging facility has successfully completed its first.
Bora Pharmaceutical Laboratories, a division of Bora Pharmaceuticals, has added roller compaction technology to its solid dose capability offerings at its Zhunan, Taiwan contract manufacturing and.
Bora Pharmaceuticals, a full-service contract development and manufacturing organisation (CDMO) which specialises in immediate and modified release tablets and capsules, along with serialised.
August 1, 2020 Volume 2020 Supplement, Issue 3 Page Number: s6-s9 By Felicity Thomas, Pharmaceutical Technology
